
Privacy notice | Accessibility statement | Terms and conditions | Login | Contact |
UK data driving real-world evidence
Bibliography
Research using CPRD data has informed drug safety guidance and clinical practice and resulted in over 2,700 peer-reviewed publications. The CPRD bibliography is updated on a monthly basis (last updated 6 April 2021) and papers are listed below and in the PDF below.
If you have published papers using CPRD data which are not included in this list, please contact us at enquiries@cprd.com so that we can update the bibliography.
Download:
(PDF, 5MB, 226 pages)This work uses data provided by patients and collected by the NHS as part of their care and support. CPRD encourages researchers to use this citation in all publications using CPRD data. Find out more about acknowledging the use of patient data at the Understanding Patient Data website.
“ACE inhibitor use and risk of cataract: a case-control analysis”, Br J Ophthalmol, 2019.
, “Achilles or biceps tendon rupture in women and men with type 2 diabetes: A population-based case-control study”, J Diabetes Complications, vol. 30, pp. 903-9, 2016.
, “Acute respiratory-tract infections and risk of first-time acute myocardial infarction”, Lancet, vol. 351, pp. 1467-71, 1998.
, “Adverse events profile of oral corticosteroids among asthma patients in the UK: cohort study with a nested case-control analysis”, Respir Res, vol. 19, p. 75, 2018.
, “Allergy, histamine 1 receptor blockers, and the risk of multiple sclerosis”, Neurology, vol. 66, pp. 572-5, 2006.
, “Angiotensin-converting enzyme inhibitors, calcium channel blockers, and breast cancer”, Arch Intern Med, vol. 160, pp. 349-53, 2000.
, “Antibiotic use and risk of multiple sclerosis”, Am J Epidemiol, vol. 163, pp. 997-1002, 2006.
, “Antibiotics and risk of subsequent first-time acute myocardial infarction”, Jama, vol. 281, pp. 427-31, 1999.
, “Anticonvulsants and congenital malformations”, Pharmacotherapy, vol. 17, pp. 561-4, 1997.
, “Antidepressant drug use and risk of venous thromboembolism”, Pharmacotherapy, vol. 28, pp. 144-50, 2008.
, “Antidepressant use during early pregnancy and the risk of congenital anomalies”, Pharmacotherapy, vol. 33, pp. 693-700, 2013.
, “Antidepressants and convulsions”, J Clin Psychopharmacol, vol. 12, pp. 241-5, 1992.
, “Antidepressants and suicide”, Bmj, vol. 310, pp. 215-8, 1995.
, “Antidepressants and the risk of suicidal behaviors”, Jama, vol. 292, pp. 338-43, 2004.
, “Antidiabetic treatment, level of glycemic control, and risk of fracture in diabetes type 2: A nested case-control study”, J Clin Endocrinol Metab, 2020.
, “Antihypertensive drugs and the risk of congenital anomalies”, Pharmacotherapy, vol. 33, pp. 476-82, 2013.
, “Antihypertensive drugs and the risk of incident rosacea”, Br J Dermatol, vol. 171, pp. 130-6, 2014.
, “Antimalarial chemoprophylaxis and the risk of neuropsychiatric disorders”, Travel Med Infect Dis, vol. 11, pp. 71-80, 2013.
, “Antipsychotic drug use and the risk of seizures: follow-up study with a nested case-control analysis”, CNS Drugs, vol. 29, pp. 591-603, 2015.
, “Antiseizure drugs and risk of developing smoking-related chronic obstructive pulmonary disease or lung cancer: A population-based case-control study”, Br J Clin Pharmacol, 2020.
, “Association between beta-blockers, other antihypertensive drugs and psoriasis: population-based case-control study”, Br J Dermatol, vol. 158, pp. 1299-307, 2008.
, “Association between glycemic control and risk of fracture in diabetic patients: A nested case-control study”, J Clin Endocrinol Metab, 2019.
, “The association between psychiatric diseases, psychotropic drugs and the risk of incident rosacea”, Br J Dermatol, vol. 170, pp. 878-83, 2014.
, “The association between thyroid disorders and incident gout: population-based case-control study”, Clin Epidemiol, vol. 9, pp. 205-215, 2017.
, “Association between use of thiazolidinediones or other oral antidiabetics and psoriasis: A population based case-control study”, J Am Acad Dermatol, vol. 58, pp. 421-9, 2008.
, “Association of childhood attention-deficit/hyperactivity disorder with atopic diseases and skin infections? A matched case-control study using the General Practice Research Database”, Ann Allergy Asthma Immunol, vol. 111, pp. 102-106.e2, 2013.
, “Association of hormone therapy and incident gout: population-based case-control study”, Menopause, vol. 22, pp. 1335-42, 2015.
, “Association of infant pneumococcal vaccination with pneumococcal pneumonia among mothers: a nested case-control study using the GPRD”, Vaccine, vol. 31, pp. 1590-6, 2013.
, “Association of smoking with amyotrophic lateral sclerosis risk and survival in men and women: a prospective study”, BMC Neurol, vol. 10, p. 6, 2010.
, “Asthma drugs and the risk of congenital anomalies”, Pharmacotherapy, vol. 33, pp. 363-8, 2013.
, “Benzodiazepine Use and Risk of Developing Alzheimer's Disease or Vascular Dementia: A Case-Control Analysis”, Drug Saf, vol. 38, pp. 909-19, 2015.
, “Bisphosphonate therapy start may transiently increase the risk of tendon rupture in patients with glucocorticoid co-medication: a population-based observational study”, Pharmacoepidemiol Drug Saf, vol. 25, pp. 1116-1123, 2016.
, “Cancer risk in association with Parkinson disease: a population-based study”, Parkinsonism Relat Disord, vol. 16, pp. 186-90, 2010.
, “Case-control analysis on metformin and cancer of the esophagus”, Cancer Causes Control, vol. 24, pp. 1763-70, 2013.
, “Chronic obstructive pulmonary disease and the risk of cardiovascular diseases”, Eur J Epidemiol, vol. 25, pp. 253-60, 2010.
, “Cigarette smoking and the progression of multiple sclerosis”, Brain, vol. 128, pp. 1461-5, 2005.
, “Colorectal cancer and markers of anemia”, Eur J Cancer Prev, vol. 27, pp. 530-538, 2018.
, “A comparison of the risk of hypoglycemia between users of human and animal insulins. 1. Experience in the United Kingdom”, Pharmacotherapy, vol. 10, pp. 395-7, 1990.
, “COPD and the risk of depression”, Chest, vol. 137, pp. 341-7, 2010.
, “CPRD Aurum database: Assessment of data quality and completeness of three important comorbidities”, Pharmacoepidemiol Drug Saf, 2020.
, “Diabetes in patients with idiopathic Parkinson's disease”, Diabetes Care, vol. 31, pp. 1808-12, 2008.
, “Diabetes mellitus and the risk of cholecystectomy”, Dig Liver Dis, vol. 43, pp. 742-7, 2011.
, “Diabetes, use of antidiabetic drugs, and the risk of glioma”, Neuro Oncol, vol. 18, pp. 340-9, 2016.
, “Diabetes, use of metformin, and the risk of meningioma”, PLoS One, vol. 12, p. e0181089, 2017.
, “Diclofenac and acute myocardial infarction in patients with no major risk factors”, Br J Clin Pharmacol, vol. 64, pp. 662-7, 2007.
, “Discontinuation and switching of therapy after initiation of lipid-lowering drugs: the effects of comorbidities and patient characteristics”, Br J Clin Pharmacol, vol. 56, pp. 84-91, 2003.
, “Does Angiotensin-Converting Enzyme Inhibitor and beta-Blocker Use Reduce the Risk of Primary Liver Cancer? A Case-Control Study Using the U.K. Clinical Practice Research Datalink”, Pharmacotherapy, vol. 36, pp. 187-95, 2016.
, “Drug-/radiation-induced interstitial lung disease in the United Kingdom general population: incidence, all-cause mortality and characteristics at diagnosis”, Respirology, vol. 17, pp. 861-8, 2012.
, “Epidemiology, co-morbidities, and medication use of patients with Alzheimer's disease or vascular dementia in the UK”, J Alzheimers Dis, vol. 35, pp. 565-73, 2013.
, “Epidemiology of basal cell carcinoma in the United Kingdom: incidence, lifestyle factors, and comorbidities”, Br J Cancer, vol. 111, pp. 203-6, 2014.
,